₹50.5
▲ +0.45 +0.90%
17 Jul 2026
BSE Listed
Fortis Malar Hospitals Limited (523696)
Volume: 8,012Avg Vol 1W: 7,186Avg Vol 1M: 7,01952W Range:₹40.75₹76
Key Ratios
Checked just nowMarket Cap₹95 Cr
Current Price₹50.5
Previous Close₹50.05
High / Low (52w)₹76 / ₹40.75
Volume8,012
Avg Vol (1W)7,186
Avg Vol (1M)7,019
Stock P/E22.85
Book Value₹18.32
Dividend Yield0%
ROE12.05%
ROA10.98%
Revenue (TTM)—
Revenue Growth—
Profit Margin8,260%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹2.21
P/B2.76
Debt / Equity0
50 DMA₹53.08
200 DMA₹57.34
Day change+0.90%
Price Chart
₹50.5▼ 29.10% · 1Y
2025-07-172026-07-17
20-day avg volume: 6K shares
Pros
- Company is almost debt-free.
- Revenue grew 134% YoY.
- Net profit is growing year over year.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹4 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹4 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹155 Cr | ₹123 Cr | ₹77 Cr | ₹94 Cr | ₹93 Cr | ₹66 Cr | ₹3 Cr | ₹6 Cr |
| EBITDA | ₹3 Cr | ₹-4 Cr | ₹-11 Cr | ₹-2 Cr | ₹-1 Cr | ₹-4 Cr | ₹1 Cr | ₹5 Cr |
| Net Profit | ₹2 Cr | ₹-9 Cr | ₹-8 Cr | ₹-8 Cr | ₹-15 Cr | ₹45 Cr | ₹0 Cr | ₹4 Cr |
| EPS | 1.09 | -4.75 | -4.2 | -4.41 | -8.26 | 24.18 | 0.21 | 2.21 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹151 Cr | ₹194 Cr | ₹169 Cr | ₹161 Cr | ₹138 Cr | ₹116 Cr | ₹37 Cr | ₹38 Cr |
| Total Liabilities | ₹45 Cr | ₹97 Cr | ₹80 Cr | ₹81 Cr | ₹74 Cr | ₹6 Cr | ₹7 Cr | ₹3 Cr |
| Equity | ₹105 Cr | ₹96 Cr | ₹89 Cr | ₹80 Cr | ₹64 Cr | ₹109 Cr | ₹30 Cr | ₹34 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹-11 Cr | ₹4 Cr | ₹-13 Cr | ₹8 Cr | ₹6 Cr | ₹-2 Cr | ₹-2 Cr | ₹-1 Cr |
| Investing | ₹6 Cr | ₹50 Cr | ₹-28 Cr | ₹8 Cr | ₹0 Cr | ₹120 Cr | ₹-29 Cr | ₹0 Cr |
| Financing | ₹0 Cr | ₹-12 Cr | ₹-7 Cr | ₹-10 Cr | ₹-13 Cr | ₹-11 Cr | ₹-80 Cr | ₹0 Cr |
| Free Cash Flow | ₹-11 Cr | ₹4 Cr | ₹-13 Cr | ₹8 Cr | ₹6 Cr | ₹-2 Cr | ₹-2 Cr | ₹-1 Cr |
Shareholding
Promoter 62.71% Institutions 0.07% Public 37.22%
Efficiency & Working Capital
ROCE13.8%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-06-30
Promoter62.7%
FII0%
DII0.1%
Institutions0.1%
Public37.2%
Promoter Pledge0%
No. of Shareholders25,734
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% | 62.7% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Public | 37.2% | 37.2% | 37.2% | 37.2% | 37.2% | 37.2% | 37.2% | 37.2% | 37.2% | 37.2% | 37.2% | 37.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 8,630 | 9,790 | 10,213 | 16,452 | 18,860 | 21,547 | 26,918 | 27,832 | 27,644 | 27,022 | 26,259 | 25,734 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Fortis Hospitals Limited | Shareholding of Promoter and Promoter Group | 62.7% | 1.18 Cr |
| Ruckmani Natarajan | Public Shareholding | 2.1% | 3,87,960 |
| Sunita Kantilal Vardhan | Public Shareholding | 1.3% | 2,37,929 |
| A M Gopalan | Public Shareholding | 1.2% | 2,31,028 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Fortis Hospitals Limited | 0 | 0% | 2026-06-30 |
| Sunita Kantilal Vardhan | 0 | 0% | 2026-06-30 |
| Ruckmani Natarajan | 0 | 0% | 2026-06-30 |
| A M Gopalan | 0 | 0% | 2026-06-30 |
| Fortis Hospitals Limited | 0 | 0% | 2026-03-31 |
| Sunita Kantilal Vardhan | 0 | 0% | 2026-03-31 |
| Ruckmani Natarajan | 0 | 0% | 2026-03-31 |
| A M Gopalan | 0 | 0% | 2026-03-31 |
| Fortis Hospitals Limited | 0 | 0% | 2025-12-31 |
| Sunita Kantilal Vardhan | 0 | 0% | 2025-12-31 |
| Ruckmani Natarajan | 0 | 0% | 2025-12-31 |
| A M Gopalan | 0 | 0% | 2025-12-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Daljit Singh | Chairman(Non Exe)&Dir(Non-Ind) | 2026 |
| RITU GARG | Non-Exec & Non-Independent Dir | 2026 |
| Shailaja Chandra | Independent Non Exe. Director | 2026 |
| Bidesh Chandra Paul | E D & Wholetime Director | 2026 |
| RICHA SINGH DEBGUPTA | Non-Exec & Non-Independent Dir | 2026 |
| Suvalaxmi Chakraborty | Independent Non Exe. Director | 2026 |
| Vinti Verma | Company Sec. & Compli. Officer | 2026 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 30 | 19 | 19 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
Substantial Acquisitions (SAST)
4 disclosure(s)
Market16/02/2024 · 50,000
Market05/01/2024 · 12,607
Market28/11/2023 · 82,219
Market17/11/2021 · 29,183
Company Information
🌐 www.fortismalar.com ↗
📍 Fortis Hospital Sector-62, Phase-VIII, Mohali, Punjab, 160062
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search